Litigation Details for Acerta Pharma B.V. v. MSN Pharmaceuticals Inc. (D. Del. 2022)
✉ Email this page to a colleague
Acerta Pharma B.V. v. MSN Pharmaceuticals Inc. (D. Del. 2022)
Docket | ⤷ Sign Up | Date Filed | 2022-02-04 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | |
Jury Demand | None | Referred To | |
Patents | 10,167,291; 10,239,883; 10,272,083; 9,290,504; 9,758,524; 9,796,721 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Acerta Pharma B.V. v. MSN Pharmaceuticals Inc.
Biologic Drugs cited in Acerta Pharma B.V. v. MSN Pharmaceuticals Inc.
The biologic drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .
Details for Acerta Pharma B.V. v. MSN Pharmaceuticals Inc. (D. Del. 2022)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2022-02-03 | 4 | Patent/Trademark Report to Commissioner of Patents | ,758,524 ;10,239,883 ;9,796,721 ;10,167,291. (mal) (Entered: 02/07/2022) 4 February 2022 PACER… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,290,504 ;9,758,524… 4 February 2022 1:22-cv-00163 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2022-02-03 | 5 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,272,083. (mal) (Entered: 02… 4 February 2022 1:22-cv-00163 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |